Related Experiment Video
Updated: Mar 3, 2026

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
Published on: August 2, 2017
Altered placental tryptophan metabolic pathway in human fetal growth restriction
Padma Murthi1, Euan M Wallace2, David W Walker2
1Department of Medicine, School of Clinical Sciences, Monash University, Monash Medical Centre, Clayton, Victoria, 3168, Australia; The Ritchie Centre, Hudson Institute of Medical Research, 27-31 Wright St., Clayton, Victoria, 3168, Australia.
Introduction:
Tryptophan is a substrate for kynurenine pathway metabolism in the placenta. We investigated if kynurenine metabolites change over gestation, if they are different between pregnancies with normal and fetal growth restriction (FGR), and if the oxygen environment modulated kynurenine pathway activity in the human placenta.
Methods:
Tryptophan, kynurenine, and downstream kynurenine metabolites were determined in maternal venous blood, umbilical cord blood, and placental samples obtained in 1st and 3rd trimester pregnancies including FGR, and in the media of placental explants incubated with 20% or 5-8% O2 for 24, 48 or 72 h.
Results:
All the major kynurenine metabolites were present in cord blood, and in general were higher than in maternal blood. IDO and TDO mRNA and protein expression, responsible for kynurenine production from tryptophan, were significantly lower in placentas from FGR pregnancies compared with control. Explants prepared from 1st and 3rd trimester placentas actively produced all the major kynurenine pathway metabolites which, together with expression of IDO, TDO, KYN-OHase and 3HAO mRNAs, were significantly lower after 24 h exposure to 5-8% O2 compared to 20% O2 CONCLUSIONS: Expression and activity of the kynurenine pathway is present in the placenta from early gestation, and is down-regulated by hypoxia and in FGR pregnancies.
Related Concept Videos
Teratogenicity
Amino Acid Biosynthetic Pathways
Inborn Errors of Metabolism
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Repressible Operon: trp Operon

